Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study*
Weissman, P., Goldstein, B. J., Rosenstock, J., Waterhouse, B., Cobitz, A. R., Wooddell, M. J., Strow, L. J.Volume:
21
Language:
english
Journal:
Current Medical Research and Opinion
DOI:
10.1185/030079905x74844
Date:
December, 2005
File:
PDF, 399 KB
english, 2005